Barbara Carrese
Overview
Explore the profile of Barbara Carrese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrese B, Coppola L, Smaldone G, DAiuto M, Mossetti G, Febbraro A, et al.
Sci Rep
. 2024 Dec;
14(1):31504.
PMID: 39733124
LAG3 plays a regulatory role in immunity and emerged as an inhibitory immune checkpoint molecule comparable to PD-L1 and CTLA-4 and a potential target for enhancing anti-cancer immune responses. We...
2.
Rosa M, Gallo E, Pellegrino P, Mercurio F, Leone M, Cascione M, et al.
ACS Appl Bio Mater
. 2024 Dec;
8(1):488-502.
PMID: 39648955
Peptide building blocks have been recently proposed for the fabrication of supramolecular nanostructures able to encapsulate and in vivo deliver drugs of a different nature. The primary sequence design is...
3.
Sanita G, Alfieri M, Carrese B, Damian S, Mele V, Cali G, et al.
RSC Med Chem
. 2024 Nov;
PMID: 39553466
In this work, we report on the synthesis and properties of a new sensitizer for photodynamic therapy applications, constituted by a ruthenium(ii) complex (1) featuring a ligand inspired from natural...
4.
Ruocco M, Gisonna A, Acampora V, DAgostino A, Carrese B, Santoro J, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892411
Breast cancers (BCs) are solid tumors composed of heterogeneous tissues consisting of cancer cells and an ever-changing tumor microenvironment (TME). The TME includes, among other non-cancer cell types, immune cells...
5.
Leone I, Santoro J, Soricelli A, Febbraro A, Santoriello A, Carrese B
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892050
Breast cancer is the most common cancer amongst women worldwide. Recently, owing to screening programs and new technologies, the survival rate has increased significantly. Breast cancer can potentially develop metastases,...
6.
Gallo E, Diaferia C, Giordano S, Rosa E, Carrese B, Piccialli G, et al.
Gels
. 2024 Jan;
10(1).
PMID: 38247735
Fmoc-diphenylalanine (Fmoc-FF) is a low-molecular-weight peptide hydrogelator. This simple all-aromatic peptide can generate self-supporting hydrogel materials, which have been proposed as novel materials for diagnostic and pharmaceutical applications. Our knowledge...
7.
Carrese B, Cavallini C, Armanetti P, Silvestri B, Cali G, Luciani G, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139203
Bioinspired nanoparticles have recently been gaining attention as promising multifunctional nanoplatforms for therapeutic applications in cancer, including breast cancer. Here, the efficiency of the chemo-photothermal and photoacoustic properties of hybrid...
8.
Santoro J, Carrese B, Peluso M, Coppola L, DAiuto M, Mossetti G, et al.
Biology (Basel)
. 2023 Dec;
12(12).
PMID: 38132355
Breast cancer is the leading cause of cancer-related death in women worldwide. It is well known that breast cancer shows significant alterations in the tumor microenvironment (TME), which is composed...
9.
Giordano S, Gallo E, Diaferia C, Rosa E, Carrese B, Borbone N, et al.
Gels
. 2023 Nov;
9(11).
PMID: 37998993
Multicomponent hydrogels (HGs) based on ultrashort aromatic peptides have been exploited as biocompatible matrices for tissue engineering applications, the delivery of therapeutic and diagnostic agents, and the development of biosensors....
10.
Carrese B, Sanita G, Lamberti A
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230578
Presently, there are no conclusive treatments for many types of cancer, mainly due to the advanced phase of the disease at the time of diagnosis and to the side effects...